首页> 外国专利> Mitochondrion: a mitochondrial based therapeutic agent that targets ketone metabolism in cancer cells.

Mitochondrion: a mitochondrial based therapeutic agent that targets ketone metabolism in cancer cells.

机译:线粒体:基于线粒体的治疗剂,靶向癌细胞中的酮代谢。

摘要

The compounds mentioned in this specification refer to the compounds that are connected with at least one ACAT 1 / 2 and oxct1 / 2 and inhibit the production of ATP mitochondria, which are called mitochondria in this document. A method for the detection of mitochondrial inhibitors and anticancer compounds is reported. It also describes the use of mitochondria to prevent or treat inflammation, bacterial infection and pathogenic yeast, as well as the use of mitochondria to prevent aging. Specific mitochondrial compounds were also reported.
机译:本说明书中提及的化合物是指与至少一种ACAT 1/2和oxct1 / 2连接并抑制ATP线粒体产生的化合物,在本文中称为线粒体。报道了一种检测线粒体抑制剂和抗癌化合物的方法。它还描述了使用线粒体预防或治疗炎症,细菌感染和致病性酵母,以及使用线粒体预防衰老。还报道了特定的线粒体化合物。

著录项

  • 公开/公告号CL2019003708A1

    专利类型

  • 公开/公告日2020-05-15

    原文格式PDF

  • 申请/专利权人 LUNELLA BIOTECH INC.;

    申请/专利号CL20190003708

  • 发明设计人 LISANTI MICHAEL P.;SOTGIA FEDERICA;

    申请日2019-12-17

  • 分类号A61K31/405;C07D209/04;

  • 国家 CL

  • 入库时间 2022-08-21 11:18:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号